In tumors that largely rely on up-regulated USP7 activity for survival and growth, the direct anti-tumor (cytotoxic) effect might be dominant; for tumors that depend on Treg cells for immune evasion, USP7 inhibitor mediated Treg suppression may prevail. Here, USP7 is linked to neoplasm.